Top compounds associated with response to KANK4


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.25 4e-08
mRNA IU1 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.11 0.0002
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.0005
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.1 0.0005
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA masitinib CTRPv2 pan-cancer AAC 0.11 0.002
mRNA lapatinib GDSC1000 pan-cancer AAC -0.15 0.002
Download CSV